Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer

Plectin-targeted liposomes/PARP inhibitor in the treatment of cancer

US Patent 11890352 · Granted Feb 6, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Hornerin: a novel non-VEGF mediated angiogenic protein expressed in both human a2024
Plectin-1 binding antibodies and uses thereof2024
Target-specific delivery of therapeutic agents2022
Target-specific delivery of therapeutic agents2022
Plectin-1 binding antibodies and uses thereof2021
Plectin-1 targeted agents for detection and treatment of pancreatic ductal adeno2018
Compositions and methods for detecting plectin-1 as a biomarker for cancer2017
Compositions and methods for diagnosing and monitoring ovarian cancer progressio2017
Plectin-1 targeted agents for detection and treatment of pancreatic ductal adeno2016
Compositions and methods for detecting plectin-1 as a biomarker for cancer2015
Plectin-1 targeted agents for detection and treatment of pancreatic ductal adeno2014
Colon tumor specific binding peptides2008